TMCI
Treace Medical Concepts Inc
NASDAQ: TMCI · HEALTHCARE · MEDICAL DEVICES
$1.81
+1.69% today
Updated 2026-04-30
Market cap
$123.74M
P/E ratio
—
P/S ratio
0.58x
EPS (TTM)
$-0.93
Dividend yield
—
52W range
$1 – $8
Volume
0.9M
Treace Medical Concepts Inc (TMCI) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | $39.42M | $57.37M | $94.42M | $141.84M | $187.12M | $209.36M | $212.69M |
| Revenue growth (YoY) | — | +45.5% | +64.6% | +50.2% | +31.9% | +11.9% | +1.6% |
| Cost of revenue | $7.63M | $12.47M | $16.89M | $27.52M | $35.18M | $41.09M | $42.94M |
| Gross profit | $31.79M | $44.90M | $77.53M | $114.31M | $151.94M | $168.26M | $169.75M |
| Gross margin | 80.6% | 78.3% | 82.1% | 80.6% | 81.2% | 80.4% | 79.8% |
| R&D | $5.07M | $5.85M | $10.20M | $13.58M | $15.44M | $20.59M | $20.28M |
| SG&A | $4.46M | $6.54M | $18.43M | $33.00M | $47.03M | $55.72M | $62.74M |
| Operating income | $-3.54M | $855000.00 | $-16.51M | $-34.84M | $-51.43M | $-55.69M | $-54.15M |
| Operating margin | -9.0% | 1.5% | -17.5% | -24.6% | -27.5% | -26.6% | -25.5% |
| EBITDA | $-2.63M | $2.06M | $-15.81M | $-36.28M | $-39.01M | $-42.07M | $-43.18M |
| EBITDA margin | -6.7% | 3.6% | -16.7% | -25.6% | -20.8% | -20.1% | -20.3% |
| EBIT | $-3.42M | $855000.00 | $-16.49M | $-38.42M | $-44.36M | $-50.49M | $-53.68M |
| Interest expense | $841000.00 | $4.52M | $4.06M | $4.40M | $5.17M | $5.26M | $5.32M |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-4.26M | $-3.67M | $-20.55M | $-42.81M | $-49.53M | $-55.74M | $-59.00M |
| Net income growth (YoY) | — | +14.0% | -460.3% | -108.3% | -15.7% | -12.6% | -5.8% |
| Profit margin | -10.8% | -6.4% | -21.8% | -30.2% | -26.5% | -26.6% | -27.7% |